Crosslinking of Ly6a metabolically reprograms CD8 T cells for cancer immunotherapy.
Ontology highlight
ABSTRACT: Crosslinking of Ly6a metabolically reprograms CD8 T cells for cancer immunotherapy.
PROVIDER: PRJNA1139138 | ENA |
REPOSITORIES: ENA
ACCESS DATA